For example, the previous study was only able to observe a statistically significant increase in BMP levels in LRRK2 G2019S carriers with PD after combining the results of 2 cohorts (45 PD/36 NMC) but not separately7. This evidence concerns the gene LRRK2 and Parkinson disease.